For a new molecular entity (NME) to become a drug, it is not only essential to have the right biological activity also be safe and efficient, but it is also required to have a favorable pharmacokinetic profile including toxicity (ADMET). Consequently, there is a need to predict, during the early sta...
Research Assistant
AI chat, annotations, notes & similar papers
No comments yet
Be the first to share your thoughts!